Why the study?
Does thapsigargin rescue the surface expression of trafficking defective LQT2 mutations without blocking HERG current in HEK293 cells?
Does thapsigargin rescue the surface expression of trafficking defective LQT2 mutations without blocking HERG current in HEK293 cells?
Thapsigargin selectively rescues the surface expression of specific trafficking-defective LQT2 mutations (G601S and F805C) without blocking the HERG channel current, demonstrating proof-of-concept for non-blocking pharmacological rescue.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for non-blocking rescue in select LQT2 mutations; leaves open translation beyond HEK293 cells.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Delisle et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: